Microcurrent Treatment for Chronic Debilitating Pain
Completed · Not applicable · Has a placebo group
Conditions studied: Pain, Opioid Use
In brief
To compare the efficacy of standard pain treatment and placebo (a microcurrent faux treatment) as opposed to standard pain treatment and microcurrent therapy in any primary care patients over a three month period.
Key facts
- Study ID
- NCT04011176
- Run by
- Paul Crawford
- People needed
- 200
- Starts
- 2019-12-09
- Expected to finish
- 2022-06-01
- Last updated by the study team
- 2024-09-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male and female Active Duty members and DoD beneficiaries
- Age 18 years or older
- Chronic debilitating pain
- PROMIS-57 T score is 60 or above
You may not qualify if…
- Pregnant
- Implanted pacemaker
- Spinal cord stimulator
- Illicit drug use including marijuana use
- Epilepsy or a history of seizures
- Other implanted device (e.g., insulin pump, opioid pump, or defibrillator)
- Chronic debilitating pain referred or recruited as measured by PROMIS-57 T score is below 60
Where it is running
- Mike O'Callaghan Military Medical Center — Nellis Air Force Base, Nevada, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.